文献速递乳腺癌支持与姑息治疗

乳腺癌诊断和治疗后患者报告症状:一项回顾性队列研究

Patient-reported symptoms after breast cancer diagnosis and treatment: A retrospective cohort study.
PubMed 文献 · Eur J Cancer · 2018-07-13

本研究基于加拿大安大略省人群数据,纳入23,840例I-III期乳腺癌术后患者,分析诊断后一年内ESAS症状评分。结果显示疲乏中度至重度发生率最高(60%),诊断后6个月为症状高峰,合并症评分高、分期晚、年轻、城市居住、低收入及治疗方式与症状评分相关。

要点

  • 诊断后一年内疲乏中度至重度发生率最高,达60%。
  • 中度至重度症状评分最常出现在诊断后6个月内。
  • 高合并症评分、晚期、年轻、城市、低收入及治疗方式与症状评分相关。

核心结论

  • 乳腺癌患者诊断后一年内症状负担高,疲乏最常见,诊断后6个月为症状高峰。
  • 高合并症评分、更晚期、年轻、城市居住、低收入及治疗方式与中度至重度及重度症状评分相关。

研究设计与样本

  • 观察性回顾性队列研究,链接癌症发病、分期、治疗和人口学数据与ESAS症状评分。
  • 纳入2007至2013年诊断的I-III期乳腺癌成年女性,以手术为主要治疗且至少有一次症状筛查记录,共23,840例,90,556次独特症状评估。

主要发现

  • 疲乏中度至重度评分发生率最高,60%患者在诊断后12个月内至少报告一次中度至重度评分。
  • 其次为健康状况受损(53%)和焦虑(44%)。
  • 中度至重度症状评分最常报告于诊断后6个月内。

关键数值与推荐

  • 中度至重度症状评分发生率:疲乏60%,健康状况受损53%,焦虑44%。
  • 与中度至重度及重度症状评分相关的因素包括:合并症评分(Aggregated Diagnosis Group ≥10)、诊断时更晚期、年轻、城市居住、低收入及治疗过程。

临床怎么用

  • 识别诊断后6个月内的症状高峰时间点及高风险亚组(高合并症、晚期、年轻、城市、低收入)。
  • 对高风险患者考虑个体化或针对性的支持性照护干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Breast cancer and its treatment are associated with varying symptoms. The province of Ontario (13.6 million) has implemented a provincial programme to screen for symptoms among cancer patients using the Edmonton Symptom Assessment System (ESAS). The purpose of this study was to describe symptom burden in the year after diagnosis among women with breast cancer. METHODS: This observational study linked cancer incidence, stage, treatment and demographic data with ESAS scores collected at cancer clinic visits. The cohort consisted of all adult women diagnosed with stage I-III breast cancer between 2007 and 2013 who received surgery as their primary treatment and had at least one symptom screening record. The prevalence and trajectory of moderate-to-severe and severe symptom scores in the year after diagnosis were described. Multivariable logistic regression models identified factors associated with moderate-to-severe and severe symptom scores. RESULTS: The cohort included 23,840 breast cancer patients and with 90,556 unique symptom assessments, within the first year from diagnosis. Tiredness had the highest incidence of moderate-to-severe scores; 60% reported at least one moderate-to-severe score in the 12 months after diagnosis, followed by impaired well-being (53%) and anxiety (44%). Elevated symptom scores were most commonly reported in 6 months after diagnosis. Higher comorbidity score (Aggregated Diagnosis Group ≥10), more advanced stage at diagnosis, younger age, urban residence, lower income and treatment course were associated with moderate-to-severe and severe symptom scores. CONCLUSION: These findings identify time points and patient subgroups at risk for elevated symptom scores and may benefit from personalised or targeted supportive care interventions.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Davis LE, Bubis LD, Mahar AL, et al. Patient-reported symptoms after breast cancer diagnosis and treatment: A retrospective cohort study. Eur J Cancer. 2018. PMID: 30014970. doi:10.1016/j.ejca.2018.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。